drugset / Trial / NCT00374790

Iron Supplementation of Lead-exposed Infants

NCT00374790

RandomizedSingle-groupDouble-blindPrevention

Summary

The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months of age.

Timeline

Start
2006-10
Primary completion
2008-05
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 12.5 mg

Indications